Using Neurocognitive Assessments to Predict and Differentiate Dementias: A Protocol for a Systematic Review

Phuong Thuy Nguyen Ho, Christopher Chen, Eric J. TanmedRxiv 2023 · DOI

Abstract: Neurocognitive impairment is the primary feature of all types of dementia. This article presents the protocol for a systematic review of the available literature on the associations between cognitive task performance and various aspects of dementia prediction, specification, and intervention outcomes.

Introduction

The global prevalence of dementia is rising at an alarming rate, with projections suggesting that 75 million individuals will be diagnosed by 2030. While recent advancements in medical technology have introduced sophisticated biomarkers—such as Positron Emission Tomography (PET) scans and cerebrospinal fluid analysis—these tools are often prohibitively expensive and inaccessible in low- and middle-income countries.

There is a critical need for cost-effective, non-invasive alternatives that can be implemented in standard clinical settings. Neurocognitive assessments, which evaluate memory, attention, and reasoning through standardized testing, offer a promising solution. However, the existing evidence regarding which specific tests are most effective at predicting cognitive decline or differentiating between dementia subtypes (e.g., Alzheimer’s disease versus Vascular dementia) remains fragmented. This protocol outlines a systematic review designed to consolidate this evidence and establish the predictive value of these assessments.

Methodological Framework

This systematic review will be conducted in strict adherence to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) guidelines to ensure transparency and reproducibility.

Search Strategy and Selection

The research team will execute a multi-threaded search across three primary databases: PubMed, Web of Science, and PsycINFO. The search strategy is built around four core concepts:

  1. Dementia
  2. Neuropsychological tests
  3. Prediction and progression
  4. Robust exclusion terms to filter out irrelevant clinical conditions.

The selection process involves two independent reviewers who will screen abstracts and full-text articles. Any discrepancies in study inclusion will be resolved through team consensus. The review will include peer-reviewed, English-language observational and intervention studies published up until January 2023.

Quality Assessment and Data Synthesis

To ensure the integrity of the findings, the researchers will utilize the Joana Briggs Institute (JBI) Critical Appraisal Tool and the Newcastle-Ottawa Scale to evaluate the risk of bias and the methodological quality of the included studies. Data extraction will focus on a wide array of variables, including participant demographics, specific neurocognitive instruments used, statistical methodologies, and the presence of confounding variables.

Strategic Objectives and Expected Insights

The protocol identifies several key areas where the systematic review aims to advance the field:

  • Functional Outcomes and Intervention: Beyond mere diagnosis, the review seeks to determine if baseline cognitive scores can predict a patient’s response to specific clinical interventions.
  • Differential Diagnosis: A primary goal is to identify neurocognitive markers sensitive enough to distinguish between different types of dementia. This is vital for tailoring treatment plans to the specific pathology of the patient.
  • Democratization of Care: By validating low-cost neurocognitive tests, the authors aim to provide clinicians worldwide—regardless of their access to high-tech imaging—with reliable tools for early detection and management.

Limitations and Future Directions

The authors acknowledge certain limitations inherent in the planned review. The restriction to English-language journals may introduce a geographic bias, potentially overlooking significant data from non-Anglophone regions. Furthermore, the exclusion of "grey literature" (such as conference proceedings or unpublished theses) may lead to publication bias, as studies with null or negative results are less likely to be published in peer-reviewed journals. Finally, the review’s reliance on formal DSM or ICD diagnostic criteria may exclude earlier research that utilized less standardized definitions of cognitive impairment.

Conclusion

As a protocol, this document establishes the rigorous methodology required to evaluate the predictive power of neurocognitive assessments. The eventual results of this systematic review are expected to characterize the predictive values of various tests, potentially leading to the development of standardized cognitive screening batteries for use in primary care settings globally.

Summary updated

Abstract

ABSTRACT Neurocognitive impairment is the primary feature of all types of dementia. This article presents the protocol for a systematic review of the available literature on the associations between cognitive task performance and various aspects of dementia prediction, specification and intervention outcomes.
BibTeX
@misc{ho2023using,
  author = {Phuong Thuy Nguyen Ho and Christopher Chen and Eric J. Tan},
  title = {{Using Neurocognitive Assessments to Predict and Differentiate Dementias: A Protocol for a Systematic Review}},
  year = {2023},
  doi = {10.1101/2023.01.10.23284251},
  howpublished = {medRxiv},
}
Figure